Alnylam Pharmaceuticals <ALNY.O>: BofA Global Research cuts price objective to $410.00 from $460.00
ALNY•Related News
Reading International Q2 FY26 net income swings to USD 2.31 million; revenue rises 11% to USD 66.9 million
RDI•
Gaxos.ai announces exercise of 3,007,654 warrants at reduced $1.2 per share price
GXAI•
Community Bancorp Q2 FY26 net income rises 15.5% to $4.7 million
CMTV•
Grains-Wheat rallies as Black Sea disruption fears grow
WEAT•
VolitionRx posts corporate deck outlining licensing-led strategy for Nu.Q diagnostics in cancer, sepsis, veterinary testing
VNRX•